An insurance start-up, a venerable health system, and a new kind of payer-provider partnership.
The election results sent biopharma stock soaring. Breaking down what’s really on tap for biopharma over the next four years.
The key to minimizing the disruption of disruptive innovation? One innovator shares lessons learned.
Why today’s digitally driven, consumer-centric health landscape requires payers to reconsider their traditional supply-and-demand thinking.
No more baby steps: Managing Partner Terry Stone writes in Harvard Business Review on the need to push harder and faster on initiatives that put focus on value, outcomes, and experience.
New political climate positions private exchanges for take-off. Learn why.
Is your organizational culture keeping pace with industry transformation? Or holding it back? Lessons from Silicon Valley.
Oscar CEO Mario Schlosser and Mount Sinai’s EVP Niyum Gandhi discuss what brought the two organizations together and how this payer-provider partnership is different.
Two scenarios for how repeal and replace changes might unfold.
Employers react to Trump win and share what the administration should prioritize when it comes to health and benefits policy.
Navigating the new checks-and-balances world of value-based pricing.
Oliver Wyman's Chief Medical Officer breaks down how healthcare providers may be impacted by an ACA repeal.
Why the path to value remains necessary to offset the high-cost/low-quality formula – no matter who is sitting in the White House.